These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37773186)

  • 1. Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction.
    Jakobsson G; Papareddy P; Andersson H; Mulholland M; Bhongir R; Ljungcrantz I; Engelbertsen D; Björkbacka H; Nilsson J; Manea A; Herwald H; Ruiz-Meana M; Rodríguez-Sinovas A; Chew M; Schiopu A
    Crit Care; 2023 Sep; 27(1):374. PubMed ID: 37773186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction.
    Marinković G; Grauen Larsen H; Yndigegn T; Szabo IA; Mares RG; de Camp L; Weiland M; Tomas L; Goncalves I; Nilsson J; Jovinge S; Schiopu A
    Eur Heart J; 2019 Aug; 40(32):2713-2723. PubMed ID: 31292614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100a8/a9 contributes to sepsis-induced cardiomyopathy by activating ERK1/2-Drp1-mediated mitochondrial fission and respiratory dysfunction.
    Wu F; Zhang YT; Teng F; Li HH; Guo SB
    Int Immunopharmacol; 2023 Feb; 115():109716. PubMed ID: 36652759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury.
    Li Y; Chen B; Yang X; Zhang C; Jiao Y; Li P; Liu Y; Li Z; Qiao B; Bond Lau W; Ma XL; Du J
    Circulation; 2019 Aug; 140(9):751-764. PubMed ID: 31220942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide.
    Vandal K; Rouleau P; Boivin A; Ryckman C; Talbot M; Tessier PA
    J Immunol; 2003 Sep; 171(5):2602-9. PubMed ID: 12928412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury.
    Wu Y; Li Y; Zhang C; A X; Wang Y; Cui W; Li H; Du J
    Hypertension; 2014 Jun; 63(6):1241-50. PubMed ID: 24711518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-oxidative, anti-inflammatory, and protective effect of S100A8 in endotoxemic mice.
    Sun Y; Lu Y; Engeland CG; Gordon SC; Sroussi HY
    Mol Immunol; 2013 Apr; 53(4):443-9. PubMed ID: 23127860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of S100A8/A9 attenuates pulmonary microvascular leakage in septic mice.
    Yu J; Zhao B; Pi Q; Zhou G; Cheng Z; Qu C; Wang X; Kong L; Luo S; Du D; Guo Y
    Respir Res; 2023 Nov; 24(1):288. PubMed ID: 37978525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term S100A8/A9 Blockade Promotes Cardiac Neovascularization after Myocardial Infarction.
    Mares RG; Suica VI; Uyy E; Boteanu RM; Ivan L; Cocuz IG; Sabau AH; Yadav V; Szabo IA; Cotoi OS; Tomut ME; Jakobsson G; Simionescu M; Antohe F; Schiopu A
    J Cardiovasc Transl Res; 2024 Dec; 17(6):1389-1399. PubMed ID: 39009944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A8/A9 in Inflammation.
    Wang S; Song R; Wang Z; Jing Z; Wang S; Ma J
    Front Immunol; 2018; 9():1298. PubMed ID: 29942307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A8/A9 promotes MMP-9 expression in the fibroblasts from cardiac rupture after myocardial infarction by inducing macrophages secreting TNFα.
    Shi S; Yi JL
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3925-3935. PubMed ID: 29949169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Resolution Dilemma: Host Antimicrobial Factor S100A8/A9 Modulates Inflammatory Collateral Tissue Damage During Disseminated Fungal Peritonitis.
    Shankar M; Uwamahoro N; Backman E; Holmberg S; Niemiec MJ; Roth J; Vogl T; Urban CF
    Front Immunol; 2021; 12():553911. PubMed ID: 33717058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A8/S100A9 deficiency increases neutrophil activation and protective immune responses against invading infective L3 larvae of the filarial nematode Litomosoides sigmodontis.
    Frohberger SJ; Fercoq F; Neumann AL; Surendar J; Stamminger W; Ehrens A; Karunakaran I; Remion E; Vogl T; Hoerauf A; Martin C; Hübner MP
    PLoS Negl Trop Dis; 2020 Feb; 14(2):e0008119. PubMed ID: 32107497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A8 and S100A9 Are Important for Postnatal Development of Gut Microbiota and Immune System in Mice and Infants.
    Willers M; Ulas T; Völlger L; Vogl T; Heinemann AS; Pirr S; Pagel J; Fehlhaber B; Halle O; Schöning J; Schreek S; Löber U; Essex M; Hombach P; Graspeuntner S; Basic M; Bleich A; Cloppenborg-Schmidt K; Künzel S; Jonigk D; Rupp J; Hansen G; Förster R; Baines JF; Härtel C; Schultze JL; Forslund SK; Roth J; Viemann D
    Gastroenterology; 2020 Dec; 159(6):2130-2145.e5. PubMed ID: 32805279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A8/A9: An emerging player in sepsis and sepsis-induced organ injury.
    Wang Q; Long G; Luo H; Zhu X; Han Y; Shang Y; Zhang D; Gong R
    Biomed Pharmacother; 2023 Dec; 168():115674. PubMed ID: 37812889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of S100A8/A9 for Cytokine Secretion, Revealed in Neutrophils Derived from ER-Hoxb8 Progenitors.
    Zhou Y; Hann J; Schenten V; Plançon S; Bueb JL; Tolle F; Bréchard S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products.
    Boyd JH; Kan B; Roberts H; Wang Y; Walley KR
    Circ Res; 2008 May; 102(10):1239-46. PubMed ID: 18403730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of S100A8/A9 proteins aggravate ventilator-induced lung injury via TLR4 signaling.
    Kuipers MT; Vogl T; Aslami H; Jongsma G; van den Berg E; Vlaar AP; Roelofs JJ; Juffermans NP; Schultz MJ; van der Poll T; Roth J; Wieland CW
    PLoS One; 2013; 8(7):e68694. PubMed ID: 23874727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A8/A9 is not involved in host defense against murine urinary tract infection.
    Dessing MC; Butter LM; Teske GJ; Claessen N; van der Loos CM; Vogl T; Roth J; van der Poll T; Florquin S; Leemans JC
    PLoS One; 2010 Oct; 5(10):e13394. PubMed ID: 20976233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.